Jennifer Herron
Director/Board Member at Gwynedd-Mercy Academy
Profile
Jennifer L.
Herron is on the board of Gwynedd-Mercy Academy.
In the past Ms. Herron was President & Executive VP-Global Commercial at MorphoSys AG, Vice President-US Immunology at Bristol Myers Squibb Co., Chief Commercial Office & Executive Vice President at ImmunoGen, Inc., Chief Commercial Officer & Executive VP of ARIAD Pharmaceuticals, Inc., Associate at Boehringer Mannheim Pharmaceuticals Corp., Chief Commercial Officer & Senior Vice President at ADC Therapeutics SA and President & EVP-Global Commercial at Bio-Rad AbD Serotec, Inc.
She received an undergraduate degree from Lehigh University and an MBA from Georgetown University.
Jennifer Herron active positions
Companies | Position | Start |
---|---|---|
Gwynedd-Mercy Academy | Director/Board Member | - |
Former positions of Jennifer Herron
Companies | Position | End |
---|---|---|
ADC THERAPEUTICS SA | Corporate Officer/Principal | 2022-11-16 |
CHEMOCENTRYX, INC. | Director/Board Member | 2022-10-19 |
IMMUNOGEN, INC. | Corporate Officer/Principal | 2019-02-28 |
ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2017-03-31 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2015-12-31 |
Training of Jennifer Herron
Lehigh University | Undergraduate Degree |
Georgetown University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 5 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
IMMUNOGEN, INC. | Health Technology |
GENOCEA BIOSCIENCES, INC. | Health Technology |
MORPHOSYS AG | Health Technology |
ADC THERAPEUTICS SA | Health Technology |
Private companies | 5 |
---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
ChemoCentryx, Inc.
ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
Bio-Rad AbD Serotec, Inc.
Bio-Rad AbD Serotec, Inc. Medical SpecialtiesHealth Technology Bio-Rad AbD Serotec, Inc. manufactured and supplied monoclonal and polyclonal antibodies to the research community. The company was headquartered in Raleigh, NC. | Health Technology |
Boehringer Mannheim Pharmaceuticals Corp. | |
Gwynedd-Mercy Academy |